D. Boral Capital

Jesse Sobelson, CFA, Vice President of Equity Research at D. Boral Capital, analyzes how deep research may impact investment strategies and operational efficiencies within your organization.

D. Boral Capital is pleased to announce our Managing Director of Healthcare Research, Jason Kolbert, has initiated coverage on Plus Therapeutics, Inc. (Nasdaq: PSTV). This coverage reflects our commitment to providing analysis of companies in the pharmaceutical industry. Access the full report and Jason’s insights on the D. Boral Capital Research Portal: https://lnkd.in/eBcyWJvh 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #PSTV

OpenAI's innovative AI agent is designed to conduct complex and in-depth research across various professional fields, including finance, science, policy, and engineering. Key features of this tool include its autonomous operation, multi-modal analysis capabilities, and time-efficient report generation. Jesse Sobelson, CFA, Vice President of Equity Research at D. Boral Capital, analyzes how Deep Research may impact investment strategies and operational efficiencies within your organization. Access the full report and Jesse’s insights on the D. Boral Capital Research Portal: https://lnkd.in/ejS7DtzS #DBoralCapital #ResearchCoverage #ArtificialIntelligence

As we mark the occasion of Holi, the Festival of Colors, at D. Boral Capital, we reflect on the significance of this joyous celebration. Holi symbolizes the triumph of good over evil and the arrival of spring, embodying the vibrant spirit of unity and diversity that enriches our global community. #DBoralCapital #Holi #FestivalOfColors #GlobalCommunity

D. Boral Capital is pleased to announce our Managing Director of Healthcare Research, Jason Kolbert, has initiated coverage on Pulmonx Corporation (Nasdaq: LUNG). This coverage reflects our commitment to providing in-depth analysis of companies in the medical technology industry. Access the full report and Jason’s insights on the D. Boral Capital Research Portal: https://lnkd.in/eZeUQpGT 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #LUNG

D. Boral Capital is pleased to highlight our Vice President of Equity Research, Jesse Sobelson initiated coverage on Aduro Clean Technologies Inc. (Nasdaq: ADUR). This coverage reflects our commitment to providing analysis of companies in the Pollution and Treatment Process industry. Access the full report and Jesse’s insights on the D. Boral Capital Research Portal: https://lnkd.in/eei7azxs 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #ADUR

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement. We would like to thank the issuer Plus Therapeutics, Inc., CEO Marc Hedrick, CFO Andrew Sims, issuer counsel William Intner, and D. Boral Capital’s counsel Ross David Carmel, Esq. Additionally, we would like to thank, Investment Banking Associate Stephen Wafalosky, Investment Banking Analyst Varun Ajjarapu, and Capital Markets Analyst Zach Perotto for their collaboration on this transaction. Press Release: https://lnkd.in/efA6-kHb Visit our website to learn more about recent transactions: 💻www.dboralcapital.com 📧 info@dboralcapital.com 📍HQ: 590 Madison Avenue 39th Floor New York, NY 10022 #DBoralCapital #PSTV #Transaction #InvestmentBank

Today and every day, D. Boral Capital celebrates the heart of our organization: our incredible team members. On this Employee Appreciation Day, we are thankful for our team's dedication and hard work. #DBoralCapital #EmployeeAppreciationDay #GlobalLeadership

D. Boral Capital is pleased to announce our Managing Director of Healthcare Research, Jason Kolbert, has initiated coverage on TEVOGEN BIO Holdings Inc. (Nasdaq: TVGN). This coverage reflects our commitment to providing in-depth analysis of companies in the healthcare industry. To access the D.Boral Capital Research portal, please visit the link below: https://lnkd.in/ewPGwwGB 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #ResearchCoverage #StockAnalysis #TVGN

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering. We would like to thank the issuer, LZ Technology Holdings Limited, issuer counsel Kevin (Qixiang) Sun 孙启翔, underwriting counsels Ying Li and Guillaume de Sampigny, and Stephanie Hu, Partner and Co-Head of Investment Banking at D. Boral Capital, for their collaboration on this transaction. Press Release: https://lnkd.in/eArjeDJ7 Visit our website to learn more about recent transactions: 💻www.dboralcapital.com 📧info@dboralcapital.com 📍HQ: 590 Madison Avenue | New York, NY 10022 #DBoralCapital #LZMH #TransactionAnnouncement #InvestmentBanking